Drug stocks flee into negative territory
Drug stocks fled with the broader market into negative territory Monday as investors reacted negatively to a warning by Bank of America that credit markets were continuing to deteriorate.
Drug stocks were in retreat early Wednesday, with UK pharmaceutical giant GlaxoSmithKline PLC the notable decliner amongst the large cap issues.